IPOUS Biotech Axiom Chooses Hong Kong Listing Over Wall StreetUS biotech firm Axiom AIOSciences is listing in Hong Kong before pursuing a US listing, a reversal of the usual playbook that reflects how competitive Asian capital markets have become for biotech and AI-adjacent listings.Jul 22, 2026
